Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt

Journal of Virology

Volumn 74, Issue 22, 2000, Pages 10681-10689

  Scholle, F ^a   Bendt, K M ^a   Raab Traub, N ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INVOLUCRIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; UVOMORULIN; VIRUS PROTEIN;

ADOLESCENT; ANCHORAGE INDEPENDENT GROWTH; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS CELL TRANSFORMATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELL TRANSPLANTATION; COLLAGEN; EPITHELIAL CELLS; FIBROBLASTS; HERPESVIRUS 4, HUMAN; HUMANS; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; ORGAN CULTURE TECHNIQUES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RETROVIRIDAE; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

EID: 0033756107     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.22.10681-10689.2000     Document Type: Article

References (57)

1. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
2. Reconstruction of 'simplifed' skin: Control of fabrication
3. Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252
4. Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia
5. Cadherins and catenins: Role in signal transduction and tumor progression
6. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
7. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness
8. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line
9. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts
10. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency
11. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases
12. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma
13. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
14. Regulation of cell death protease caspase-9 by phosphorylation
15. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
16. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation
17. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
18. Ribosomal S6 kinase signaling and the control of translation
19. Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion
20. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
21. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
22. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction
23. Tyrosine 112 of latent membrane protein 2a is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency
24. Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-13-3 isoforms and P11
25. Induction of NF-κB by the Akt/PKB kinase
26. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
27. Epstein-Barr virus and its replication
28. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase
29. Antibodies to LMP2A/2B in EBV-carrying malignancies
30. Integrin-mediated activation of MAP kinase is independent of FAK: Evidence for dual integrin signaling pathways in fibroblasts
31. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase
32. Regulation of Epstein-Barr virus latency by latent membrane protein 2
33. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential
34. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
35. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
36. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking
37. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes
38. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B- and p70(s6k)-dependent pathway
39. Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells
40. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
41. Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase
42. Clonal proliferations of cells infected with Epstein-Barr virus in pre-invasive lesions related to nasopharyngeal carcinoma
43. Phosphorylation and activation of p70s6k by PDK1
44. Epstein-Barr virus infection in nasopharyngeal carcinoma
45. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
46. EBV associated malignancies
47. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
48. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt
49. Two related Epstein-Barr virus membrane proteins are encoded by separate genes
50. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase
51. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: A role for C-terminal Src kinase
52. Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts
53. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion
54. Involucrin and other markers of keratinocyte terminal differentiation
55. Signal transduction by lymphocyte antigen receptors
56. Epstein-Barr virus gene expression in nasopharyngeal carcinoma
57. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-13-3 not BCL-X(L)